| 标题 |
Safety and antitumor activity of 3-weekly anti-EpCAM antibody adecatumumab (MT201) in combination with docetaxel for patients with metastatic breast cancer: Results of a multicenter phase Ib trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:M. Sebastian; C. Hanusch; M. Schmidt; N. Marschner; D. Oruzio; et al 出版日期:2009 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)